Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23


Lung Cancer is an international publication covering the clinical, translational and basic science of malignancies of the lung and chest region.

To access this content, you need to be an ESMO member, please login

Access Lung Cancer

What type of papers does Lung Cancer publish?

The Editors welcome submissions of original research articles, early reports, review articles, editorials and correspondence covering the prevention, epidemiology and etiology, basic biology, pathology, clinical assessment, surgery, chemotherapy, radiotherapy, combined treatment modalities, other treatment modalities and outcomes of lung cancer.

Why publish with Lung Cancer?

  • Journal Impact Factor 5.3 (2022) and CiteScore 10.3 (2022) 
  • Rigorous peer review by noted experts in the field

ESMO members are entitled to receive a 20% discount on the journal's article publication charge for all papers submitted after January 1st 2023. Find out more about joining ESMO

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.